BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Harris MA, Hawkins CJ. Recent and Ongoing Research into Metastatic Osteosarcoma Treatments. Int J Mol Sci 2022;23:3817. [PMID: 35409176 DOI: 10.3390/ijms23073817] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 5.0] [Reference Citation Analysis]
Number Citing Articles
1 Hua L, Lei P, Hu Y. Construction and validation model of necroptosis-related gene signature associates with immunity for osteosarcoma patients. Sci Rep 2022;12:15893. [PMID: 36151259 DOI: 10.1038/s41598-022-20217-4] [Reference Citation Analysis]
2 Cui Y, Dong YY. ZCCHC12 promotes the progression of osteosarcoma via PI3K/AKT pathway. Aging (Albany NY) 2022;14. [PMID: 36126191 DOI: 10.18632/aging.204296] [Reference Citation Analysis]
3 Wang H, Liu H, Wang L, Xu S, Pi H, Cheng Z, Zheng M. Subtype Classification and Prognosis Signature Construction of Osteosarcoma Based on Cellular Senescence-Related Genes. Journal of Oncology 2022;2022:1-15. [DOI: 10.1155/2022/4421952] [Reference Citation Analysis]
4 Moukengue B, Lallier M, Marchandet L, Baud’huin M, Verrecchia F, Ory B, Lamoureux F. Origin and Therapies of Osteosarcoma. Cancers 2022;14:3503. [DOI: 10.3390/cancers14143503] [Reference Citation Analysis]
5 Wang J, Jin J, Chen T, Zhou Q. Curcumol Synergizes with Cisplatin in Osteosarcoma by Inhibiting M2-like Polarization of Tumor-Associated Macrophages. Molecules 2022;27:4345. [DOI: 10.3390/molecules27144345] [Reference Citation Analysis]
6 Madda R, Chen C, Chen C, Wang J, Wu H, Wu P, Chen W. Analyzing BMP2, FGFR, and TGF Beta Expressions in High-Grade Osteosarcoma Untreated and Treated Autografts Using Proteomic Analysis. IJMS 2022;23:7409. [DOI: 10.3390/ijms23137409] [Reference Citation Analysis]